Waters Corporation stock drops again as analysts reset targets after BD deal
Waters Corp shares fell 2.8% to $320 in late New York trading Thursday, extending losses after a weak first-quarter profit outlook and broker price target cuts. Wells Fargo, BofA, UBS, and TD Cowen all lowered targets, citing integration risks with BD’s biosciences and diagnostics units. Waters completed the $18.8 billion BD deal this week, with BD shareholders now owning 39.2% of the combined company.